浅谈临床常见血栓与止血一般检验的注意事项与结果分析  

Discussion on the General Inspection of Clinical Common Thrombosis and Hemostasis

作　　者：刘冰冰[1] 王冬丽[1] 

机构地区：[1]漯河医学高等专科学校第三附属医院,462000

出　　处：《中国继续医学教育》2015年第27期46-47,共2页China Continuing Medical Education

摘　　要：止血和血栓涉及临床许多疾病的发生和发展,并与临床治疗和预后有密切的关系,因此临床要求进行血栓与止血方面检查的标本和项目越来越多,这些检验项目广泛应用于出血、血栓性疾病及血栓前状态的诊断、鉴别诊断、疗效观察、抗凝药物剂量监测和手术前凝血功能检验等。在血栓与止血项目的检验过程中,许多凝血因子检测可受多种因素干扰,加强实验的质量控制尤为重要。凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原三者同时检测已被临床用于筛查患者凝血机制是否正常,特别是心胸外科、骨科、妇产科等手术前检查患者的凝血功能尤为重要。Hemostasis and thrombosis related to many clinical diseases, the occurrence and development and in the clinical treatment and prognosis have close relations, so the clinical requirement of thrombosis and hemostasis check specimen and the project more and more, the inspection items are widely used in the hemorrhage, thrombosis and thrombus former state diagnosis, differential diagnosis, curative effect observation, anticoagulant drug dose monitoring and preoperative coagulation function test, etc. In the process of the project inspection of thrombosis and hemostasis, many clotting factors interference detection is affected by many factors, is particularly important to strengthen the quality control of experiment. Prothrombin time, activated partial thrombin time live enzymes, and fibrinogen detection has been clinically used for screening the patient whether normal blood clotting mechanism, especially the cardiothoracic surgery, orthopedics, gynecology and obstetrics, etc before examine a patient＆#39;s blood coagulation function is particularly important.

关 键 词：血栓与止血检验 凝血因子 外源性凝血途径 内源性凝血途径 

分 类 号：R446[医药卫生—诊断学]